Drug recall · July 15, 2015
Magnesium Sulfate Injection recall
Why: Failed pH Specifications: 12 month stability testing
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Magnesium Sulfate Injection, USP, 50%, 20mL, Single dose Fliptop Vial, For IV or IM use, Rx only, Manufactured by Hospira, Inc. 4285 Wesleyan Blvd Rocky Mount, NC 27804 for Hospira, Inc. 275 N Field Drive, Lake Forest, IL 60045. NDC 0409-2168-02
- Lots / codes
Lot #: 39-569-DK, Exp 3/1/2016
- Quantity
- 106,900 vials
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- U.S. Nationwide, Kuwait, Bahrain and Israel.
- Initiated
- May 19, 2015 · Voluntary: Firm initiated
- Classified
- July 8, 2015
- Reported
- July 15, 2015
- Ended
- December 4, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Magnesium sulfate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.